Helix BioPharma Corp. to Participate in Upcoming Momentum Women(TM) Event in New York Focused on Women's Health and Wellness

AURORA, ON--(Marketwire - Apr 18, 2011) - Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), a developer of biopharmaceutical drug candidates for the prevention and treatment of cancer, today announced that it will participate in the upcoming Momentum Women™ event on April 20, 2011, in New York City. The event will include medical experts on women's health topics including cervical cancer management and prevention and will reference Helix's Topical Interferon Alpha-2b developmental drug candidate. Helix BioPharma is also a sponsor of this event.

Ceslie Armstrong, founder of Momentum Women™, will host the event featuring wellness experts, including Shobha S. Krishnan, MD, a primary care physician and gynecologist at Barnard Health Services, Columbia University, New York. Discussion of current and future management of cervical cancer, human papilloma virus ("HPV") infections and precancerous cervical disease, will include Helix's novel approach under development for the treatment of HPV-induced low-grade cervical lesions, which can lead to cervical cancer.

Dr. Krishnan has been involved in the area of primary care and women's health for over 25 years. She has extensive experience in the field of HPV and HPV-related diseases, such as cervical cancer. She has practiced as a surveillance physician for the Centers for Disease Control and Prevention, sits on the Medical Advisory Board of the National Cervical Cancer Coalition, resides on the expert's panel of the American Social Health Association and is the Founder and President of the Global Initiative Against HPV and Cervical Cancer.

"We are delighted to participate in this event to help women become more aware of HPV and cervical cancer," said John Docherty, President and COO of Helix BioPharma.

"We are very pleased to partner with Helix BioPharma for our upcoming event, and support their work in the development of their Topical Interferon Alpha-2b drug candidate," said Ceslie Armstrong. "As a cervical cancer survivor, I am grateful for the work Helix BioPharma is doing in the area of cervical cancer prevention. The well-being of women is the core of our programming and through identifying experts, products and companies like Helix BioPharma that care greatly about women, we are privileged to bring this incredibly important information to our audience."

About Momentum Women™

This event was founded in 2006 by the social networking and live event division of the company Momentum Women™ Media & Entertainment that produces, syndicates, and distributes original programming for women across multiple screens and platforms. The programming mantra of "Stylish, Healthy, and Informed" ensures content that encourages, spotlights, and celebrates products and companies supporting the empowerment and wellness of women and their families. For more information about this organization, please visit their website at